Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 20, 2008

View Archived Issues

MOTIVATE, MERIT studies detail activity of maraviroc in HIV infection

DUET-1 and DUET-2: Results at 48 weeks with TMC-125 in HIV infection

Cognitive improvement seen with intranasal insulin in early Alzheimer's disease

Atazanavir/ritonavir as effective as lopinavir/ritonavir in treatment-naive HIV patients

Recent patents impart new therapeutic agents for respiratory and allergic disorders

Novel therapeutic options for cancer described in recent patent literature

Novel antiinflammatory agents claimed in recent patents

Pharmexa provides update on company plans

Improved pharmacokinetics of Pfizer's novel long-acting, inhaled beta2 receptor agonist

Chelsea receives SPA for pivotal phase III droxidopa study

Hollis-Eden files IND for Apoptone in hormone-sensitive cancers

Lenalidomide receives orphan drug status in Japan

Roche completes tender offer for Ventana Medical Systems

Bionomics receives USD 1 million milestone payment from Genmab

Memory and Roche to initiate biomarker clinical study of MEM-3454 for schizophrenia

Alligator Bioscience and ImmuRx enter into strategic collaboration

PLx Pharma initiates phase I clinical trial of Aspirin-PC

Potency of sipuleucel-T is reported to be correlated with patient survival

Antitumor mechanism of marine lipopeptide elucidated

Protectan CBLB-502 significantly decreases adverse effects of chemotherapy in mice

FDA accepts NDA for Treanda in relapsed indolent non-Hodgkin's lymphoma

DSMB recommends continuation of Oxford BioMedica's TroVax phase III study

InNexus Biotechnology announces second preclinical antibody targeting cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...